Cardiol Therapeutics (OTCMKTS:CRTPF) Trading 6.1% Higher

Cardiol Therapeutics Inc. (OTCMKTS:CRTPFGet Free Report)’s share price traded up 6.1% during mid-day trading on Monday . The company traded as high as $1.94 and last traded at $1.92. 231,732 shares were traded during mid-day trading, an increase of 245% from the average session volume of 67,097 shares. The stock had previously closed at $1.81.

Cardiol Therapeutics Trading Up 6.1 %

The company has a 50 day simple moving average of $1.45 and a 200 day simple moving average of $1.08.

About Cardiol Therapeutics

(Get Free Report)

Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.

Read More

Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.